Search tips
Search criteria 


Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS One. 2011; 6(11): e27496.
Published online 2011 November 15. doi:  10.1371/journal.pone.0027496
PMCID: PMC3216985

Enhancement of Canonical Wnt/β-Catenin Signaling Activity by HCV Core Protein Promotes Cell Growth of Hepatocellular Carcinoma Cells

Ben C. B. Ko, Editor



The Hepatitis C virus (HCV) core protein has been implicated as a potential oncogene or a cofactor in HCV-related hepatocellular carcinoma (HCC), but the underlying mechanisms are unknown. Overactivation of the Wnt/β-catenin signaling is a major factor in oncogenesis of HCC. However, the pathogenesis of HCV core-associated Wnt/β-catenin activation remains to be further characterized. Therefore, we attempted to determine whether HCV core protein plays an important role in regulating Wnt/β-catenin signaling in HCC cells.


Wnt/β-catenin signaling activity was investigated in core-expressing hepatoma cells. Protein and gene expression were examined by Western blot, immunofluorescence staining, RT-qPCR, and reporter assay.

Principal Findings

HCV core protein significantly enhances Tcf-dependent transcriptional activity induced by Wnt3A in HCC cell lines. Additionally, core protein increases and stabilizes β-catenin levels in hepatoma cell line Huh7 through inactivation of GSK-3β, which contributes to the up-regulation of downstream target genes, such as c-Myc, cyclin D1, WISP2 and CTGF. Also, core protein increases cell proliferation rate and promotes Wnt3A-induced tumor growth in the xenograft tumor model of human HCC.


HCV core protein enhances Wnt/β-catenin signaling activity, hence playing an important role in HCV-associated carcinogenesis.


Hepatocellular carcinoma (HCC) ranks among the most common and deadly cancers worldwide [1]. HBV and HCV infection, alcohol abuse and exposure to aflatoxin B have been identified as major risk factors [2][4]. HCC associated with HCV infections evolves after many years of chronic infection and is generally preceded by the development of cirrhosis. However, the mechanisms underlying HCV-associated hepatocarcinogenesis are not fully understood.

HCV core is a 191 amino acid protein with RNA binding activity and may transactivate some transcription factors, such as NF-κB, AP-1 and SREBP [5][7]. It has been reported that HCV core protein may directly modulate hepatocyte proliferation and transformation through regulating important several signaling pathways [8][10], suggesting that HCV core protein may play an important role in the pathogenesis of HCV-induced neoplastic transformation of hepatocytes. However, molecular mechanism underlying HCV-induced neoplastic transformation remains to be thoroughly elucidated.

Aberrant activation of Wnt/β-catenin signaling results in enhanced cell growth and malignant cellular transformation. Inactivating mutations of APC, oncogenic mutations of β-catenin, upregulation of Frizzled type receptors (Fzds), and/or other Wnt signaling pathway alterations, play important roles in more than 33–67% of HCCs [11][14]. Fukutomi [15] recently reported that HCV core protein can up-regulate Wnt-1 and WISP-2 expression in Huh7 cells, leading to an increased cell proliferation, DNA synthesis and cell cycle progression. These findings suggest that activation of the Wnt/β-catenin signaling pathway may contribute significantly to the hepatocellular carcinogenesis.

In this study, we sought to investigate whether HCV core protein exerts any effect on Wnt/β-catenin signaling pathway and hence is involved in HCV-induced liver pathogenesis. We found that HCV core protein acts synergistically with Wnt3A on β-catenin-dependent transcriptional activity in HCC cell lines, and co-expression of core and Wnt3A induces stabilization and nuclear translocation of β-catenin, contributing to up-regulation of Wnt target gene expression. Cells transduced with both core and Wnt3A exhibit rapid proliferation, enhanced cell cycle progression. Co-expression of core and Wnt3A in HCC cells leads to an accelerated tumor formation in athymic nude mice. Thus, these data strongly suggested that Wnt/β-catenin signaling may be potentiated by core protein and hence play an important role in HCV pathogenesis.

Materials and Methods

Cell culture and chemicals

HEK293 cells [16] and human HCC lines HepG2, Huh7 [17] and SMMC-7721 [18] were maintained in complete Dulbecco's Modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS, Hyclone), 100 units/ml penicillin, and 100 µg/ml streptomycin at 37°C in 5%CO2. Human colon cancer cell line HCT116 [16] and Mouse hepatic progenitor cell line HP14.5 that was derived from mouse E14.5 fetal liver were also used in this study [19][20]. Unless indicated otherwise, all chemicals were purchased from Sigma-Aldrich.

Construction of recombinant adenoviruses expressing HCV core and Wnt3A

For generating adenoviral vector expressing HCV core protein, the full-length of HCV core protein (genotype 1a) was PCR amplified from plasmid H/FL (kindly provided by Dr. Charles M. Rice of Rockefeller University, USA) [21] and subcloned into the shuttle vector pAdTrack-TO4. The adenoviral recombinant pAd-Core was subsequently generated and amplified in HEK293 cells using the AdEasy system [22]. Adenovirus expressing Wnt3A, namely AdWnt3A, was generated previously using the AdEasy system [16], [19]. In addition to the expression of transgenes, both Ad-Core and AdWnt3A also express GFP as a marker for monitoring infection efficiency. An analogous adenovirus expressing only GFP (AdGFP) was used as a control [16], [23].

Preparation of Wnt3A conditioned medium

Wnt3A conditioned medium was prepared as described [16]. Briefly, subconfluent HCT116 cells (in 75 cm2 flaks) were infected with an optimal titer of AdWnt3A or AdGFP control. At 15 hr post-infection, the culture medium was changed to serum-free DMEM. Conditioned medium was collected at 48 hr after infection and used immediately.

Luciferase assay

Cells were seeded in 25 cm2 cell culture flasks and transfected with 2 µg per flask of β-catenin/Tcf4-responsive luciferase reporter, pTOP-Luc [16], [22][23] using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. A Renilla luciferase reporter plasmid (Promega) was mixed as an internal control. At 16 hr after transfection, cells were replated to 24-well plates. At 4 hr after replating, cells were infected with AdGFP, Ad-Core, AdWnt3A, AdWnt3A plus Ad-Core or AdWnt3A plus AdGFP. At 24 hr after infection, cells were lysed and subjected to luciferase assays using Promega's Dual Luciferase Kit. Each assay condition was performed in triplicate.

Immunofluorescence staining

Cells were fixed with 4% formaldehyde, permeabilized with 0.5% Triton, and followed by incubating with an anti-β-catenin antibody (Santa Cruz, sc-7199) overnight. After being washed, cells were incubated with Alexa Fluor 594-labeled secondary antibody (Invitrogen) for 45 min. Cells were counterstained with DAPI to label nuclei. The presence of β-catenin was visualized under a confocal immunofluorescence microscope.

Western blotting analysis

Nuclear and cytoplasmic proteins were separated using Pierce's NE-PER Nuclear and Cytoplasmic Extraction Reagent according to the manufacturer's instructions. Whole cell extracts of exponentially growing cells were collected in lysis buffer (Promega) containing the complete cocktail of proteases inhibitors (Roche). Protein concentrations were determined by using the BCA protein assay reagent (Pierce). Approximately 50–70 µg of proteins were resolved on 10% polyacrylamide gels and electrotransferred to PVDF membranes (Millipore). The blots were probed with antibodies against β-catenin (Santa Cruz, sc-7199), HCV core (Abcam, ab2740), Wnt3A ( Cell Signaling, #2391), c-Myc (Santa Cruz, sc-764), cyclin D1 (Santa Cruz, sc-753), GSK3β (Santa Cruz, sc-9166) and phosphor (Ser9)-GSK3β (Cell Signaling, #9323). Secondary antibodies coupled to HRP were purchased from Jackson ImmunoResearch Laboratories. Proteins of interest were detected with Super Signal West Pico Chemiluminescent substrate Kits (Pierce).

RNA isolation and quantitative RT-PCR analysis

Total RNAs were extracted from cultured cells using TRIZOL Reagents (Invitrogen) according to the manufacturer's protocol. Total RNA was used to generate cDNA templates by RT reaction with random hexamer and MMLV RT (Promega). The cDNA products were further diluted 5- to 10-fold and used as qPCR templates. The primer sequences used to detect the expression of HCV core, c-Myc, cyclin D1, CTGF and WISP2 are listed in Table 1. Endogenous GAPDH expression was used as a normalization control. SYBR Green-based qPCR analysis was carried out using the DNA Engine Opticon 2 real-time PCR detection system (Bio-Rad, CA, USA). Duplicate reactions were carried out for each sample, and all samples were normalized by the expression level of GAPDH.

Table 1
Primer Sequences for RT-PCR.

MTS proliferation assay

MTS assays were performed with the Cell Titer 96 AQ One Solution Cell Proliferation Assay (Promega). 20 ul MTS reagent was added to each well of the 96 well assay plate and incubated the plate for 2 hr at 37°C in 5% CO2. The absorbance at 490 nm was recorded every 24 hr in triplicate until day 4 by using a microplate reader (Synergy HT Multi-mode Microplate Reader, Bio-Tek). Each condition was repeated at least three times.

Crystal violet cell viability assay

The crystal violet staining procedure was carried out as described [24][25]. Briefly, cells were fixed in 10% buffered formalin for 20 min and then stained with 0.5% crystal violet solution at room temperature for 30 min. The plates were washed and allowed to air dry and incubated with 0.2% Triton X-100 for 30 min at room temperature to dissolve the dye. Then, 100 µl samples from each well were transferred into 96-well microplates and read the absorbance at 570 nm in the microplate reader Synergy HT Multi-mode Microplate Reader (Bio-Tek).

Cell cycle analysis

Cells were prepared for cell cycle analysis as described [26]. Briefly, cells were collected and fixed with 70% ethanol at 4°C. For flow cytometric assay, cells were washed with PBS and resuspended in propidium iodide (PI) staining solution. Samples were processed by using the FACSVantage SE (Becton Dickinson). The acquired data were analyzed using the CellQuest software (Becton Dickinson).

Xenograft tumor model of human HCC in athymic nude mice

The care and use of experimental animals was in compliance with the institutional guidelines approved for our study. Athymic nude mice (4–6 week old, male, 18–25 g) were used for the studies. Huh7 cells were infected with AdGFP control, Ad-Core, AdGFP plus AdWnt3A, or Ad-Core plus AdWnt3A for 15 hr, and collected for subcutaneous injection (5×106/injection) into the flanks of athymic nude (nu/nu) mice (n = 6 mice per group). At 6 wk after implantation, animals were sacrificed, and tumor masses were retrieved for histological analysis.

Immunohistochemical staining

Retrieved xenograft samples were fixed with 4% paraformaldehyde, embedded and sectioned. Sections were incubated with β-catenin, c-Myc, cyclin D1 (Santa Cruz) or Ki67 (Santa Cruz, sc-23900) antibodies. Subsequently, the slides were incubated with EnVision System-HRP (DakoCytomation) and visualized using DAB substrate (DakoCytomation).

Statistical analysis

The data were presented as mean ± SD. Statistical analysis was performed using the SPSS 15.0 software. Differences between groups were compared by the ANOVA test. In all assays, the probability value (p) of <0.05 was considered statistically significant. Error bars represent SDs of three independent experiments.


HCV core protein plays an important role in activating Tcf-dependent transcriptional activity in hepatoma cells

In order to study the biological functions of HCV core protein in HCC cells, we first sought to construct and generate a recombinant adenovirus Ad-Core to effectively express core protein in target cells. As shown in Fig. S1, Ad-Core can effectively infect hepatocytes and express the transgene.

To determine the effects of HCV core protein on Wnt/β-catenin signaling, we then analyzed the endogenous β-catenin/Tcf activity in hepatoma cells by using pTOP-Luc lucifearse reporter assay. As shown in Fig. 1A, endogenous reporter activity was maintained at a basal level in Huh7, SMMC-7721 and mouse hepatic progenitor cell line HP14.5 [19][20], whereas Wnt signaling is already activated in HepG2 cells which harbor an oncogenic β-catenin mutation [27].

Figure 1
HCV core potentiates Wnt3A-induced TOP-Luc activity in hepatoma cells.

Immunostaining analysis indicated β-catenin was localized predominantly to cytoplasm and cytoplasmic membrane in SMMC-7721 and Huh7 cells. In contrast, in HepG2 cells nuclear staining of β-catenin was apparently observed with high cytoplasmic β-catenin accumulation (Fig. 1B). These results indicate that the basal β-catenin/Tcf activity is low in Huh7 or SMMC-7721 cells.

We next examined whether HCV core protein can potentiate Wnt/β-catenin signaling activity by measuring Tcf-4 dependent transcriptional activity. As shown in Fig. 1C and D, exogenous expression of Wnt3A or core alone exhibited limited activation of the TOP-Luc reporter in Huh7 and SMMC-7721 cells. And these findings are supported by an early report [27]. However, when Ad-Core and AdWnt3A were co-infected into Huh7 or SMMC-7721 cells, Wnt3A-induced Tcf-4 dependent transcriptional activity was enhanced by core protein in a dose-dependent manner, whereas the GFP control had no synergistic effect on Wnt3A-induced transcriptional activity. These results suggest that ectopic expression of HCV core can potentiate Wnt3A-induced TOP-Luc activity in Huh7 and SMMC-7721 cells.

HCV core protein increases and stabilizes β-catenin levels in hepatoma cells through inactivation of GSK-3β

The hallmark of canonical Wnt signaling activation is cytoplasmic and nuclear accumulation of stabilized β-catenin protein. To examine the subcellular distribution of β-catenin in hepatoma cells producing core protein, we infected Huh7 cells with Ad-Core, AdGFP, AdWnt3A or Ad-Core plus AdWnt3A, and then detected β-catenin expression level in the cytoplasmic and nuclear fractions. As expected, co-expression of HCV core and Wnt3A induced β-catenin accumulation both in nuclear and cytosolic fraction. However, apparent nuclear translocation of β-catenin was not examined in GFP control cells (Figure 2A).

Figure 2
HCV core increases β-catenin levels in nuclear fractions through inactivation of GSK3β in Huh7 cells.

To corroborate these findings, we next analyzed cellular localization of β-catenin in SMMC-7721 cells by immunostaining. Cells were infected with a comparable titer of AdGFP, Ad-Core, AdWnt3A or AdWnt3A plus Ad-Core (Figure 2B, panels a, e, i and m. GFP fluorescence shows infected cells). Consistent with the immunoblotting results, partially nuclear translocation of β-catenin was observed when cells were infected with Ad-Core but not GFP control (Figure 2B, panels b to d; f to h). This nuclear translocation effect was further strengthened when core and Wnt3A were co-expressed (Figure 2B, panels n to p), Similar results for nuclear translocation of β-catenin induced by HCV core were obtained in hepatoma cell lines Huh7 cells using immunostaining assay (Fig. S2).

In order to eliminate possible interference caused by adenovirus co-infections, we further examined the subcellular distribution of β-catenin in core-expression cells by using Wnt3A conditioned medium instead of adenovirus co-infections. Briefly, Huh 7 or HepG2 cells were infected with AdCore or AdGFP for 24 h, and then stimulated with Wnt3A conditioned medium for 0, 2 and 4 h. The cytoplasmic and nuclear fractions were prepared for immunoblotted with an anti-β-catenin antibody. We found that β-catenin levels were significantly increased in the nuclear fraction of core-expression hepatoma cells, peaked at 4 hrs after Wnt3A stimulation, corresponding to a simultaneous decrease of β-catenin protein level in the cytoplasmic fraction (Fig. S3). Taken together, these results suggest that HCV core may induce β-catenin accumulation and nuclear translocation, thus leading to the activation of Tcf4-dependent transcriptional regulation.

We next investigated the possible mechanism through which core protein induces β-catenin accumulation. Phosphorylation of β-catenin by GSK-3β causes its degradation through the ubiquitin-proteasome system. We examined whether accumulation and stabilization of β-catenin in core-expressing cells was resulted from inactivation of GSK3β. Since β-catenin is mutated and partially localized in the nucleus of HepG2 cells (Figure 1B and Fig. S3B), this cell line is a suitable negative control to elucidate the role of GSK3β inactivation in core-expression cells. Not surprisingly, the ratio of p-GSK-3β vs. total GSK-3β was much higher in HepG2 cells than that of Huh7 cells at basal condition (Figure 2C). Phosphorylation of GSK-3β at the Ser-9 residue in HCV core-expressing Huh7 cells was much stronger than that in GFP control cells (Figure 2C, Top panel). Quantitative analysis indicated that p-GSK-3β expression level in core-expressing cells was nearly 3-fold of GFP control's. The increased phosphorylation of GSK3β was further potentiated when cells were co-infected with Ad-Core and Ad-Wnt3A (Figure 2D, p<0.05). It is well established that Ser-9 phosphorylation inactivates GSK-3β kinase activity [28]. Thus, these data strongly suggest that HCV core may up-regulate β-catenin through inactivation of GSK-3β by phosphorylation at serine-9.

Additive effect of HCV core protein on up-regulation of Wnt/β-catenin downstream target genes

The activation of Wnt/β-catenin signaling pathway leads to transcriptional regulation of Wnt-responsive genes, which regulate cell proliferation and cell migration [15], [29]. The c-Myc, cyclin D1, CTGF and WISP2 are well-known target genes of canonical Wnt signaling [22], [30][31], and some of them are known to be over-expressed in HCC tissues [32]. Next we tested whether HCV core could up-regulate Wnt signaling in Huh7 cells. As shown in Fig. 3A and 3B, when cells were co-infected with Ad-Core and AdWnt3A, mRNA expression levels of c-Myc, cyclin D1, CTGF and WISP2 were approximately 1.7-, 1.5-, 1.2- and 1.8-fold higher than that in AdWnt3A-infected cells (p<0.05). Western blot analysis indicated that the protein expression of c-Myc and cyclinD1 were further elevated in these cells than in Wnt3A-treated cells (Fig. 3C). Thus, these findings, together with the results from Tcf4- reporter assays and nuclear β-catenin localization experiments, have demonstrated that exogenous expression of HCV core in Huh7 cells enhances Wnt3A-induced Tcf-dependent transcriptional activity, promotes β-catenin nuclear translocation, and additively up-regulates the expression of Wnt-target genes, such as c-Myc and cyclin D1.

Figure 3
HCV core enhances Wnt3A-induced target genes expression.

HCV core increases cell proliferation rate and promotes cell cycle progression

We next examined the effect of HCV core protein on biological functions of Wnt/β-catenin signaling. As shown in Figure 4A, over-expression of HCV core alone resulted in an increased proliferation rate in Huh7 cells. A similar growth-promoting activity by HCV core alone was observed by cell viability assay (Figure 4B). Moreover, cells co-infected with Ad-Core and AdWnt3A showed stronger proliferation capacity than AdWnt3A or Ad-Core-treated cells at 96 hr post infection (p<0.05). Quantitative viability analysis confirmed the additive effect of HCV core on Wnt3A-induced growth promotion (Figure 4C, p<0.05).

Figure 4
HCV core promotes cell proliferation in Huh7 cells.

Furthermore, we determined whether cell cycle progression was affected by HCV core protein. The cell cycle analysis showed that the S-phase distribution in cells transduced with core, Wnt3A or core plus Wnt3A were 32.37%, 33.2% and 35.69% respectively (Figure 4D), much higher than that of GFP control (23.10%) (p<0.05). Quantitative cell cycle analysis from three batches of experiments showed ectopic expression of core, Wnt3A or core plus Wnt3A significantly promoted G1- to S-phase transition in Huh7 cells, especially at 72 hr and 120 hr post-infection (Table S1). Thus, HCV core can accelerate cell proliferation which may contribute to the increase in cell numbers in S-phase. These data were consistent with the results of core protein-promoted proliferation and viability assay. Taken together, the above data strongly suggest that HCV core may be involved in promoting the transition of cells from the G1-phase to S-phase of the cell cycle, consistent with the well-recognized growth-promoting activity of Wnt/β-catenin signaling.

Core protein synergizes with Wnt/β-catenin signaling in promoting xenograft tumor growth

We further investigated the tumorigenic activity in HCC cells co-infected with core and Wnt3A. Huh7 cells were infected with a comparable titer of AdGFP, Ad-Core, AdWnt3A plus AdGFP or AdWnt3A plus Ad-Core (Figure 5A), and then injected into nude mice subcutaneously. All mice injected with core, Wnt3A plus GFP or Wnt3A plus core formed xenograft tumors within 6 weeks after inoculation, and tumor sizes in mice injected with Wnt3A and core co-infected cells were much larger than that of either core or Wnt3A alone (Figure 5B, p<0.01). On the other hand, none of mice injected with GFP control showed tumor formation for up to 10 weeks, indicating that Huh7 cells are not highly tumorigenic under our experimental conditions. Hematoxylin & eosin staining of the retrieved tumor samples revealed that tumor cells with multinuclear and frequent mitosis were surrounded by fibrous connective tissues (Figure 6A, panels a to c). Immunohistochemical (IHC) analysis with a Ki-67 antibody revealed that cell proliferation activities were increased in cells co-infected with Wnt3A plus HCV core. Meanwhile, strong β-catenin protein expression was observed in cytoplasm and whole cells (Figure 6B, panels d to f; g to i). We also examined the protein expression of Wnt/β-catenin targets c-Myc and cyclin D1 by IHC staining. As shown in Figure 6B, there was a dramatic increase in the expression level of c-Myc (panels j to l) and cyclin D1 (data not shown) after co-expression of Wnt3A and core in hepatoma cells. Taken together, these in vivo results suggest that HCV core protein may potentiate Wnt/β-catenin-induced tumor growth in HCC xenograft model.

Figure 5
Over-expression of HCV core promotes Wnt3A-induced xenograft tumor growth in vivo.
Figure 6
HCV core promotes cell proliferation in xenograft tumors.


Although both virus-induced and immunologically-mediated hepatocytes damage play an important role in pathogenesis, the mechanisms underlying HCV persistence and pathogenesis have been poorly understood. HCV core protein has been reported to play a critical role in HCV-associated liver diseases by activation of several cellular signal transduction, direct interaction with proto-oncogenes [33][34], and to transform cell lines and induce tumors in transgenic mouse models [10], [35][37]. Recently, HCC-derived core protein has been shown to shift TGF-β responses from tumor suppression to epithelial-mesenchymal transition (EMT), which contributes to the promotion of cell invasion and metastasis [17].

In the present study, we sought to investigate whether HCV core protein directly activates Wnt/β-catenin signaling pathway and hence is involved in HCV-induced liver pathogenesis. We found that HCV core protein synergizes Wnt3A-mediated β-catenin-dependent transcriptional activity in hepatocytes and HCC cells. Moreover, co-expression of core and Wnt3A gene induces stabilization and nuclear translocation of β-catenin, contributing to the up-regulation of Wnt-target gene expression, such as c-Myc and cyclin D1. We further demonstrated that cells transduced with core and Wnt3A exhibited increased proliferation, promoted cell cycle progression and accelerated tumor formation in athymic nude mice. Our results are supported by several studies on interaction between virus-encoded proteins and Wnt/β-catenin tumorigenic signaling. For example, HCV NS5A protein was shown to activate β-catenin signaling cascades through increasing the stability of β-catenin [38]. HBV X protein along with Wnt-1 activated Wnt/β-catenin signaling in Huh7 cells [27].

The stabilization and accumulation of β-catenin can be achieved by two possible mechanisms. One mechanism is Wnt-dependent stabilization of β-catenin, which was modulated by several components upstream of β-catenin molecule [18]. The other mechanism is phosphorylation of GSK3β at the Ser9 residue. GSK3β is a critical component that controls the distribution balance of β-catenin between cytoplasm and nucleus. Inactivation of GSK3β leads to the accumulation of β-catenin in the cytoplasm. Many growth factors, including IGF-1, EGF and HGF have been implicated in GSK3β inhibition [39][41]. It has been reported that GSK3β activity can be modulated by virus-encoded proteins. For example, the latent membrane protein 2A of Epstein-Barr virus and Hepatitis B virus X protein have been shown to enhance β-catenin accumulation through Ser9 phosphorylation of GSK3β [27], [42]. Erk-mediated inactivation of GSK3β may be involved in HBx- and growth factor-induced β-catenin stabilization [28]. Recently, the nonstructural 5A (NS5A) protein of HCV has been shown to inactivate GSK3β activity and subsequently increase accumulation of β-catenin in hepatoma cells [38]. Here, we demonstrated that the phosphorylation of GSK3β was increased in core-expression cells, indicating core may up-regulate β-catenin through inactivation of GSK-3β by phosphorylation at Serine-9. Further studies should be directed to explore the molecular mechanism behind stabilization of β-catenin involving GSK3β phosphorylation.

Exogenous core expression was shown to enhance Wnt3A-stimulated HCC tumor growth, possibly by inducing β-catenin accumulation and oncogene overexpression. Interestingly, in xenogarft animal model nuclear translocation of β-catenin in tumor cells was less prominent. There are several possible explanations. First, previous data showed that neoplastic hepatoma cells with nuclear accumulation of β-catenin were restricted to the periphery of tumor nodules or were in small tumor regions detached from large nodules [43]. The liver tissue sampling we used may not include this region; therefore, nuclear accumulation of β-catenin can not be readily observed. Secondly, Huh7 cells were classified as “well-differentiated” hepatoma cells according to the epithelial gene expression profile [44], while nuclear accumulation of β-catenin was correlated with the dedifferentiation of tumor cells to immature hepatocyte progenitors [45]. Thus, the differentiation status of xenograft tumors may determine the subcellular distribution of β-catenin. Lastly some components upstream of β-catenin may be negatively modulated in Huh7 cells, leading to inhibition of β-catenin translocation. It is conceivable that some if not all of the above possibilities may be responsible for the β-catenin immunostaining results in xenograft tumors.

In summary, by co-expressing HCV core protein and Wnt3A in hepatocytes and HCC cell lines, we have found that the HCV core protein can potentiate and synergize with Wnt/β-catenin signaling pathway in promoting cell proliferation and tumor growth. These results strongly suggest that HCV core, possibly through synergizing Wnt-induced stabilization and accumulation of β-catenin, may play an important role in HCV pathogenesis. Nonetheless, the exact role of HCV core in Wnt/β-catenin-induced HCC tumorigenesis remains to be fully investigated. Ultimately, this line of investigation may lead to the development of novel anti-HCV therapies by targeting both HCV itself and the canonical Wnt signaling pathway.

Supporting Information

Figure S1

The recombinant adenovirus effectively expresses core protein in target cells. (A) Effective infection of hepatocytes with Ad-Core. Huh7 or HP14.5 cells were infected with Ad-Core and the infection efficiency was examined under a fluorescence microscope. BF: blank field. Magnification, (400. (B) Ectopic expression of HCV core in Huh7 cells. Huh7 cells were infected with Ad-Core, AdWnt3A or AdGFP control for 36(hr. Total RNA was isolated for RT-PCR analysis using primers specific for HCV core gene (a), and protein expression was determined by Western blotting using anti-core antibody (Abcam) (b). Endogenous GAPDH expression was used as a control.


Figure S2

HCV core increases the nuclear translocation of β-catenin induced by Wnt3A. Huh7 cells were infected with AdGFP (panels a to d), Ad-Core (panels e to h), AdWnt3A (panels i to l) or Ad-Core plus AdWnt3A (panels m to p) for 24 hr. Cells were fixed and subjected to immunofluorescence staining as described in Figure 1. Nuclear translocation of β-catenin was indicated by yellow arrows.


Figure S3

Ectopic expression of HCV core enhances nuclear accumulation of β-catenin in Huh7 and HepG2 cells. Subconfluent hepatoma Huh7 (A) and HepG2 (B) cells were infected with Ad-Core or AdGFP for 24 hr, and stimulated with Wnt3A conditioned medium for 0, 2 and 4 hr. Both cytosolic (C) and nuclear (N) fractions were prepared and subjected to Western blotting analysis with an anti-β-catenin antibody. The subcellular fractions were verified by immunoblotting analysis using either anti-β-tubulin or lamin B1 antibody. WT, wild type; Mut, mutant β-catenin.


Table S1

Cell Cycle (S Phase) analysis.



We thank Dr. Charles M. Rice of Rockefeller University, USA for kind provision of plasmid H/FL, Tingxiu Xiang for help with immunofluorescence microscopy.


Competing Interests: The authors have declared that no competing interests exist.

Funding: This work was supported in part by research grants from China National Natural Science Foundation (#30972586, NT; #30972584, PH), Natural Science Foundation Project of CQ CSTC (2009BA5036, NT), Natural Science Foundation Project of CQMU (NT), Program for Changjiang Scholars and Innovative Research Team in University (#IRT0872, HR) and Major National S&T program (2008ZX10001-016, ALH; 2008ZX10002-006, HR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


1. Bosch FX, Ribes J, Borràs J. Epidemiology of primary liver cancer. Semin Liver Dis. 1999;19:271–285. [PubMed]
2. Buendia MA. Hepatitis B viruses and hepatocellular carcinoma. Adv Cancer Res. 1992;59:167–226. [PubMed]
3. dilman R, De Maria N, Colantoni A, Van Thiel DH. Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma. J Viral Hepatol. 1998;5:285–299. [PubMed]
4. Montesano R, Hainaut P, Wild CP. Hepatocellular carcinoma: from gene to public health. J Natl Cancer Inst. 1997;89:1844–1851. [PubMed]
5. Lai MM, Ware CF. Hepatitis C virus core protein: possible roles in viral pathogenesis. Curr Top Microbiol Immunol. 2000;242:117–134. [PubMed]
6. Marusawa H, Hijikata M, Chiba T, Shimotohno K. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappa B activation. J Virol. 1999;73:4713–4720. [PMC free article] [PubMed]
7. Otsuka M, Kato N, Lan K, Yoshida H, Kato J, et al. Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. J Biol Chem. 2000;275:34122–34130. [PubMed]
8. Tsuchihara K, Hijikata M, Fukuda K, Kuroki T, Yamamoto N, et al. Hepatitis C virus core protein regulates cell growth and signal transduction pathway transmitting growth stimuli. Virology. 1999;258:100–107. [PubMed]
9. Delhem N, Sabile A, Gajardo R, Podevin P, Abadie A, et al. Activation of the interferon-inducible protein kinase PKR by Hepatocellular carcinoma derived-Hepatitis C virus core protein. Oncogene. 2001;20:5836–5845. [PubMed]
10. Yoshida T, Hanada T, Tokuhisa T, Kosai K, Sata M, et al. Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation. J Exp Med. 2002;196:641–654. [PMC free article] [PubMed]
11. Breuhahn K, Longerich T, Schirmacher P. Dysregulation of growth factor signaling in human hepatocellular carcinoma. Oncogene. 2006;25:3787–3800. [PubMed]
12. Austinat M, Dunsch R, Wittekind C, Tannapfel A, Gebhardt R, et al. Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma. Mol Cancer. 2008;7:21. [PMC free article] [PubMed]
13. Lee HC, Kim M, Wands JR. Wnt/Frizzled signaling in hepatocellular carcinoma. Front Biosci. 2006;11:1901–1915. [PubMed]
14. Merle P, de la Monte S, Kim M, Herrmann M, Tanaka S, et al. Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma. Gastroenterology. 2004;127:1110–1122. [PubMed]
15. Fukutomi T, Zhou Y, Kawai S, Eguchi H, Wands JR, et al. Hepatitis C virus core protein stimulates hepatocyte growth: correlation with upregulation of Wnt1 expression. Hepatology. 2005;41:1096–1105. [PubMed]
16. Tang N, Song WX, Luo J, Luo X, Chen J, et al. BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signaling. J Cell Mol Med. 2009;13:1901–1915. [PubMed]
17. Battaglia S, Benzoubir N, Nobilet S, Charneau P, Samuel D, et al. Liver cancer-derived hepatitis C virus core proteins shift TGF-Beta responses from tumor suppression to epithelial-mesenchymal transition. PLoS ONE. 2009;4:e4355. [PMC free article] [PubMed]
18. Liu J, Wang Z, Tang J, Tang R, Shan X, et al. Hepatitis C virus core protein activates Wnt/β-catenin signaling through multiple regulation of upstream molecules in the SMMC-7721 cell line. Arch Virol. 2011;156(6):1013–23. [PubMed]
19. Huang J, Bi Y, Zhu GH, He Y, Su Y, et al. Retinoic acid signaling induces the differentiation of mouse fetal liver-derived hepatic progenitor cells. Liver International. 2009;29:1569–1581. [PubMed]
20. Bi Y, Huang JY, He Y, Zhu GH, Su YX, et al. Wnt Antagonist SFRP3 Inhibits the Differentiation of Mouse Hepatic Progenitor Cells. J Cell Biochem. 2009;108:295–303. [PubMed]
21. Blight KJ, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science. 2000;290:1972–4. [PubMed]
22. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, et al. Identification of c-MYC as a target of the APC pathway. Science. 1998;281(5382):1509–12. [PubMed]
23. Luo JY, Deng ZL, Luo XJ, Tang N, Song WX, et al. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc. 2007;2(5):1236–1247. [PubMed]
24. Castro-Garza J, Barrios-García HB, Cruz-Vega DE, Said-Fernández S, Carranza-Rosales P, et al. Use of a colorimetric assay to measure differences in cytotoxicity of Mycobacterium tuberculosis strains. J Med Microbio. 2007;56:733–737. [PubMed]
25. Chen L, Jiang W, Huang J, He BC, Zuo GW, et al. Insulin-like growth factor 2 (IGF2) potentiates BMP9-induced osteogenic differentiation and bone formation. J Bone Miner Res. 2010;25(11):2447–59. [PMC free article] [PubMed]
26. Juan G, Traganos F, Darzynkiewicz Z. Methods to identify mitotic cells by flow cytometry. Meth Cell Biol. 2001;63:343–354. [PubMed]
27. Cha MY, Kim CM, Park YM, Ryu WS. Hepatitis B virus X protein is essential for the activation of Wnt/β-catenin signaling in hepatoma cells. Hepatology. 2004;39:1683–1693. [PubMed]
28. Ding Q, Xia W, Liu JC, Yang JY, Lee DF, et al. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. Mol cell. 2005;19:159–170. [PubMed]
29. Tanaka S, Sugimachi K, Kameyama T, Maehara S, Shirabe K, et al. Human WISP1, a member of the CCN family, is associated with invasive cholangiocarcinoma. Hepatology. 2003;37:1122–1129. [PubMed]
30. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398(6726):422–6. [PubMed]
31. Xu L, Corcoran RB, Welsh JW, Pennica D, Levine AJ. WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene. Genes Dev. 2000;14(5):585–95. [PubMed]
32. McGivern DR, Lemon SM. Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene. 2011;30(17):1969–83. [PMC free article] [PubMed]
33. Clarke B. Molecular virology of hepatitis C virus. J Gen Virol. 1997;78:2397–2410. [PubMed]
34. Zhu N, Khoshnan A, Schneider R, Matsumoto M, Dennert G, et al. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol. 1998;72:3691–3697. [PMC free article] [PubMed]
35. Ray RB, Lagging LM, Meyer K, Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol. 1996;70:4438–4443. [PMC free article] [PubMed]
36. Kato T, Miyamoto M, Date T, Yasui K, Taya C, et al. Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice. Cancer Sci. 2003;94:679–685. [PubMed]
37. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med. 1998;4:1065–1067. [PubMed]
38. Park CY, Choi SK, Kang SM, Kang JI, Ahn BY, et al. Nonstructural 5A protein activates beta-catenin signaling cascades: implication of hepatitis C virus-induced liver pathogenesis. J Hepatol. 2009;51:853–864. [PubMed]
39. Cohen P, Frame S. The renaissance of GSK3. Nat Rev Mol Cell Biol. 2001;2(10):769–776. [PubMed]
40. Cheon SS, Nadesan P, Poon R, Almen BA. Growth factors regulate beta-catenin-mediated TCF-dependent transcriptional activation in fibroblasts during the proliferative phase of wound healing. Exp Cell Res. 2004;293:267–274. [PubMed]
41. Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoël MJ, Bertrand F, Cherqui G, et al. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. Oncogene. 2001;20:252–259. [PubMed]
42. Morrison JA, Klingehutz AJ, Raab-Traub N. Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells. J Virol. 2003;77:12276–12284. [PMC free article] [PubMed]
43. Huang H, Fujii H, Sankila A, Mahler-Araujo BM, Matsuda M, et al. Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am J Pathol. 1999;155:1795–1801. [PubMed]
44. Wei W, Chua MS, Grepper S, So Sk. Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells. Mol Can. 2009;8:76. [PMC free article] [PubMed]
45. Zulehner G, Mikula M, Schneller D, van Zijl F, Huber H, et al. Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence. Am J Pathol. 2010;176(1):472–481. [PMC free article] [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science